Pharma companies may post near double-digital fall in Q4 PAT
Updated: April 9, 2018 04:03 PM IST
Pharmaceutical companies are likely to report dismal number in Q4 of FY18 due to sustained pricing pressure, customer consolidation, rising competition and rupee appreciation.